Cpf1 (Cas12a)
E1150780
UNEXPLORED
Cpf1 (Cas12a) is a CRISPR-associated endonuclease used for genome editing that recognizes different DNA target sequences and creates staggered cuts, offering distinct advantages and applications compared to Cas9.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Cpf1 (Cas12a) canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T15313581 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cpf1 (Cas12a) Context triple: [CRISPR-Cas9 gene-editing technology, hasVariant, Cpf1 (Cas12a)]
-
A.
CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
-
B.
phiC31 integrase system
The phiC31 integrase system is a site-specific recombination tool widely used in genetic engineering to insert DNA precisely into defined genomic locations.
-
C.
CASP13
CASP13 is the 13th Critical Assessment of protein Structure Prediction experiment, an international community-wide competition that benchmarks computational methods for predicting 3D protein structures.
-
D.
CTCF
CTCF is a state prison facility in Colorado that houses incarcerated individuals under the jurisdiction of the Colorado Department of Corrections.
-
E.
DNA ligase
DNA ligase is an essential enzyme that joins breaks in the sugar-phosphate backbone of DNA, enabling processes such as DNA replication and genetic recombination.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Cpf1 (Cas12a) Target entity description: Cpf1 (Cas12a) is a CRISPR-associated endonuclease used for genome editing that recognizes different DNA target sequences and creates staggered cuts, offering distinct advantages and applications compared to Cas9.
-
A.
CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
-
B.
phiC31 integrase system
The phiC31 integrase system is a site-specific recombination tool widely used in genetic engineering to insert DNA precisely into defined genomic locations.
-
C.
CASP13
CASP13 is the 13th Critical Assessment of protein Structure Prediction experiment, an international community-wide competition that benchmarks computational methods for predicting 3D protein structures.
-
D.
CTCF
CTCF is a state prison facility in Colorado that houses incarcerated individuals under the jurisdiction of the Colorado Department of Corrections.
-
E.
DNA ligase
DNA ligase is an essential enzyme that joins breaks in the sugar-phosphate backbone of DNA, enabling processes such as DNA replication and genetic recombination.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.